Friday 6 November 2026 Export JAZZ’s income statement to Excel — free account

Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 4.88% from fiscal 2024.

Revenue: +10.4%
EPS: −280.5%
Free cash flow: −60.4%
Total debt: +3.88%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

235.28 7.96 +3.50%

Follow JAZZ

Alert me

Market cap: $14.6B
P/E: 62.6×
Fwd P/E: 35.9×
Dividend yield: —
F-score: 5/9
Altman Z: 1.37
Beneish M: −3.03
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	63.63	15.80	410.98	0.00	+8 more quarters Free account
P/S ratio Full definition →	3.17	3.31	2.64	2.43
P/FCF ratio Full definition →	22.54	10.75	37.30	32.79
P/Operating CF Full definition →	29.60	36.64	28.67	28.60
P/B ratio Full definition →	3.57	3.17	2.58	2.40
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	3.75	3.78	3.20	3.11
EV/EBITDA Full definition →	15.46	10.76	21.01	49.93
EV/Operating CF Full definition →	10.45	10.46	10.63	9.80
EV/FCF Full definition →	26.62	12.27	45.21	42.02
Quick Ratio Full definition →	1.47	1.38	1.65	1.46
Current Ratio Full definition →	1.82	1.78	2.04	1.86
Net Debt/EBITDA Full definition →	(11.57)	5.04	4.79	6.72
Debt/Assets Full definition →	46.42%	39.27%	45.15%	45.96%
Debt/Equity Full definition →	1.33	0.91	1.18	1.24
Asset Turnover Full definition →	0.40	0.42	0.38	0.36
Operating CF/Net income Full definition →	(1.05)	2.16	1.39	1.78
Capex/Depreciation Full definition →	(0.07)	(0.53)	(0.11)	(5.02)
Interest Coverage Full definition →	(9.09)	6.69	8.44	5.61
Research and Development Expense of Revenue Full definition →	17.05%	17.17%	18.34%	17.86%
Selling, General and Administrative Expense of Revenue Full definition →	32.82%	32.21%	33.00%	33.91%
Intangible Assets out of Total Assets Full definition →	0.50	0.53	0.51	0.54
Share Based Compensation of Revenue Full definition →	6.21%	6.07%	6.97%	5.91%
Graham Net Nets Full definition →	(0.21)	(0.15)	(0.23)	(0.31)
Graham Number Full definition →	72.83	161.46	27.53	0.00
Earnings Yield Full definition →	1.57%	6.33%	0.24%	(3.41%)
Free Cash Flow Yield Full definition →	4.44%	9.30%	2.68%	3.05%
Revenue per Share Full definition →	19.21	19.12	17.27	19.65
Operating CF per Share Full definition →	7.82	6.58	6.59	5.94
Capex per Share Full definition →	(0.20)	(1.50)	(0.32)	(14.76)
Free Cash Flow per Share Full definition →	7.62	5.07	6.28	(8.82)
Cash per Share Full definition →	44.15	34.81	46.43	40.04
Shareholders Equity per Share Full definition →	64.79	75.98	73.22	70.82
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	64.79	75.98	73.22	70.82
Free Cash Flow Full definition →	493.10	320.60	388.50	(537.66)
Working Capital Full definition →	2,080.20	1,737.40	2,336.50	1,923.50
Capital Expenditures Full definition →	(13.00)	(95.10)	(19.70)	(900.14)
Net Current Asset Value Full definition →	(3,192.50)	(2,311.00)	(2,744.20)	(3,174.70)
EV/EBIT Full definition →	41.54	19.38	0.00	0.00
Capex to Sales Full definition →	0.01	0.08	0.02	0.75
Price to Operating Income Full definition →	35.17	16.98	0.00	0.00
Other line items
Average Receivables Full definition →	819.03	797.45	744.65	773.73
Average Payables Full definition →	266.26	108.93	97.97	99.98
Average Inventory Full definition →	468.56	473.99	465.14	448.72
Average Assets Full definition →	11,677.10	11,012.52	11,697.14	11,835.78
Average Common Equity Full definition →	4,075.42	4,254.03	4,353.60	4,206.18

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly